Regenxbio (RGNX) EBITDA (2014 - 2026)
Regenxbio (RGNX) posted quarterly EBITDA of -$57.6 million for Q4 2025, down 12.2% year-over-year from -$65.6 million in Q4 2024, and down 9.97% quarter-over-quarter from -$52.4 million in Q3 2025.
Regenxbio (RGNX) EBITDA (2014 - 2026) Analysis & Trends
Regenxbio's EBITDA history runs 12 years deep, the most recent figure standing at -$57.6 million for Q4 2025.
- In Q4 2025, EBITDA fell 12.2% year-over-year to -$57.6 million; the TTM figure through Dec 2025 stood at -$161.2 million (up 30.92% YoY), while the FY2025 annual figure was -$161.2 million, up 30.92% from the prior year.
- EBITDA for Q4 2025 stood at -$57.6 million, down from -$52.4 million in the prior quarter.
- The five-year high for EBITDA was $313.6 million in Q4 2021, with the low at -$73.1 million in Q2 2023.
- The 5-year median for EBITDA is -$59.9 million (2022), against an average of -$38.3 million.
- Peak annual rise in EBITDA reached 684.51% in 2021, while the deepest fall reached 511.07% in 2021.
- Regenxbio's EBITDA stood at $313.6 million in 2021, then plunged by 118.42% to -$57.8 million in 2022, then retreated by 10.61% to -$63.9 million in 2023, then advanced by 19.62% to -$51.4 million in 2024, then fell by 12.2% to -$57.6 million in 2025.
- Business Quant data shows RGNX's EBITDA at -$57.6 million in Q4 2025, -$52.4 million in Q3 2025, and -$63.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 29.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.26 Mn |
| Dec 31, 2025 | -57.64 Mn |
| Sep 30, 2025 | -52.41 Mn |
| Jun 30, 2025 | -63.28 Mn |
| Mar 31, 2025 | 12.13 Mn |
| Dec 31, 2024 | -51.37 Mn |
| Sep 30, 2024 | -62.08 Mn |
| Jun 30, 2024 | -56.04 Mn |
| Mar 31, 2024 | -63.86 Mn |
| Dec 31, 2023 | -63.90 Mn |
| Sep 30, 2023 | -64.96 Mn |
| Jun 30, 2023 | -73.11 Mn |
| Mar 31, 2023 | -66.16 Mn |
| Dec 31, 2022 | -57.77 Mn |
| Sep 30, 2022 | -71.05 Mn |
| Jun 30, 2022 | -62.53 Mn |
| Mar 31, 2022 | -71.53 Mn |
| Dec 31, 2021 | 313.60 Mn |
| Sep 30, 2021 | -57.35 Mn |
| Jun 30, 2021 | -52.23 Mn |